These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
715 related articles for article (PubMed ID: 10615932)
21. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Kim S; Lim DH; Lee J; Kang WK; MacDonald JS; Park CH; Park SH; Lee SH; Kim K; Park JO; Kim WS; Jung CW; Park YS; Im YH; Sohn TS; Noh JH; Heo JS; Kim YI; Park CK; Park K Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1279-85. PubMed ID: 16099596 [TBL] [Abstract][Full Text] [Related]
22. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. Hoffman JP; Lipsitz S; Pisansky T; Weese JL; Solin L; Benson AB J Clin Oncol; 1998 Jan; 16(1):317-23. PubMed ID: 9440759 [TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas. Redmond KJ; Wolfgang CL; Sugar EA; Ahn J; Nathan H; Laheru D; Edil BH; Choti MA; Pawlik TM; Hruban RH; Cameron JL; Herman JM Ann Surg Oncol; 2010 Dec; 17(12):3112-9. PubMed ID: 20680697 [TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study. Splinter TA; Obertop H; Kok TC; Jeekel J J Cancer Res Clin Oncol; 1989; 115(2):200-2. PubMed ID: 2715169 [TBL] [Abstract][Full Text] [Related]
26. Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma. Abrams RA Cancer J; 2012; 18(6):624-32. PubMed ID: 23187851 [TBL] [Abstract][Full Text] [Related]
27. Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Bassi C; Stocken DD; Olah A; Friess H; Buckels J; Hickey H; Dervenis C; Dunn JA; Deakin M; Carter R; Ghaneh P; Neoptolemos JP; Buchler MW; Dig Surg; 2005; 22(5):353-63. PubMed ID: 16293966 [TBL] [Abstract][Full Text] [Related]
28. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. Mehta VK; Fisher G; Ford JA; Poen JC; Vierra MA; Oberhelman H; Niederhuber J; Bastidas JA J Gastrointest Surg; 2001; 5(1):27-35. PubMed ID: 11309645 [TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy following surgery for periampullary and pancreatic cancers. Sonkar AA; Poston GJ Eur J Surg Oncol; 2004 Nov; 30(9):911-2. PubMed ID: 15498632 [No Abstract] [Full Text] [Related]
30. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience. Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062 [TBL] [Abstract][Full Text] [Related]
31. Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial. Vaillant JC; Nordlinger B; Deuffic S; Arnaud JP; Pelissier E; Favre JP; Jaeck D; Fourtanier G; Grandjean JP; Marre P; Letoublon C Ann Surg; 2000 Apr; 231(4):449-56. PubMed ID: 10749603 [TBL] [Abstract][Full Text] [Related]
32. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Abrams RA; Yeo CJ Surg Oncol Clin N Am; 2004 Oct; 13(4):621-38, ix. PubMed ID: 15350938 [TBL] [Abstract][Full Text] [Related]
33. Survival analysis of pancreatic and periampullary collision cancers. Niu GM; Jin DY; Ji Y; Hou J; Wang DS; Lou WH J Dig Dis; 2010 Aug; 11(4):231-6. PubMed ID: 20649736 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Kalser MH; Ellenberg SS Arch Surg; 1985 Aug; 120(8):899-903. PubMed ID: 4015380 [TBL] [Abstract][Full Text] [Related]
35. Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure. Paulino AC Am J Clin Oncol; 1999 Oct; 22(5):489-94. PubMed ID: 10521065 [TBL] [Abstract][Full Text] [Related]
36. Management of a patient with borderline resectable pancreatic cancer. Case report and review. Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606 [TBL] [Abstract][Full Text] [Related]
37. Role of adjuvant therapy in the management of pancreatic cancer. Laheru D; Yeo CJ Adv Surg; 2005; 39():223-44. PubMed ID: 16250554 [No Abstract] [Full Text] [Related]
38. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322 [TBL] [Abstract][Full Text] [Related]
39. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137 [TBL] [Abstract][Full Text] [Related]
40. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]